ADA Scientific Sessions 2026 Abstract

Semaglutide in Kidney Transplant Recipients: Real-World Evidence on Safety and Efficacy

By Elamin Abdelgadir, Salma Elnour, Azza Abdulaziz Khalifa, Fatheya Alawadi

Study in peopleInterventions

The paper

Elamin Abdelgadir, Salma Elnour, Azza Abdulaziz Khalifa, Fatheya Alawadi

Dubai

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2817-LB

doi.org/10.2337/db26-2817-lb

Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs